Question 1

Has Kabir Mody received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,446,226 in general payments to Kabir Mody across 539 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Kabir Mody did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Kabir Mody come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AstraZeneca	59	$1,476,573
EMD Serono, Inc.	169	$496,630
Incyte Corporation	211	$235,363
Puma Biotechnology, Inc.	14	$105,828
Agios Pharmaceuticals, Inc.	41	$45,146
Ipsen Bioscience Inc.	5	$25,949
Seagen Inc.	2	$20,750
Astrazeneca UK Limited	1	$10,973
Ipsen Biopharmaceuticals, Inc	10	$7,324
Exelixis Inc.	9	$6,681
Genentech USA, Inc.	5	$5,523
Taiho Oncology, Inc.	3	$4,400
Biocompatibles, Inc.	2	$2,480
Boston Scientific	2	$2,117
Astrazeneca AB	2	$188
Novocure Inc.	1	$138
Amgen	1	$91
Merck	1	$46
Bristol Myers Squibb	1	$26

Kabir Mody

Payments from drug & device makers

Who reported the general payments

How this compares

Other hematology & oncology in Jacksonville